Amphastar Pharma (AMPH) Tops Q1 EPS by 6c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $79.8 million versus the consensus estimate of $76.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
• Mannatech (MTEX) Tops Q2 EPS by 53c